Tools


Home > News > INFOBIOMED: Structur...


news

INFOBIOMED: Structuring European Biomedical Informatics to Support Individualised Healthcare.

The Research Unit on Biomedical Informatics (GRIB) of the Institut Municipal d’Investigació Mèdica (IMIM) coordinates the only European Network of Excellence granted to Catalonia and endowed with a budget of 5 million euros. This network, called “Structuring European Biomedical Informatics to Support Individualised Healthcare (INFOBIOMED)”, is funded by the European Commission within the VI Framework Programme for Research and Technological Development (RTD).

The idea of INFOBIOMED, which brings together 16 European organisations, is to create a stable and lasting RTD structure on Biomedical Informatics. Biomedical Informatics is an emerging discipline placed in the confluence between Bioinformatics (computer science applied to the analysis of the genomic and proteomic information) and Medical Informatics (information technologies to support healthcare). These disciplines have been developed in an independent form, but show now great opportunities for interaction and synergistic cooperation.

The genomic revolution is offering interesting opportunities for significant improvements in disease prevention, diagnosis and treatment, with a view on continuity and individualisation of healthcare, with the aim of improving the health and quality of life of the citizens, as well as to efficiency of the expenditure of the healthcare system. This new approach (Genomic Medicine) needs a parallel development of innovative strategies and tools for information management and analysis, which are the ones afforded by Biomedical Informatics. 

Therefore, the mission of INFOBIOMED will consist of providing scientific and technological knowledge and experiences on the application of information technologies to the Genomic Medicine. 

The INFOBIOMED network, which is coordinated by Ferran Sanz, Head of the GRIB, professor and Research Vicechancelor of the Universitat Pompeu Fabra (UPF), is composed by: Fundació IMIM, Institut Municipal d’Investigació Mèdica, Instituto de Salud Carlos III, Karolinska Institute, Edinburgh University, Custodix, Universidad Politécnica de Madrid, Universidad de Aveiro, Foundation for Research and Technology-Hellas, Danish Centre for Health Telematics, Informa S.r.l, Heinrich-Heine Universität Düsseldorf, Erasmus MC-University Medical Center Rótterdam, Hvidovre Hospital, Academisch Centrum Tandheelkunde Amsterdam, and AstraZeneca Research and Development. 



Site Information